On the afternoon of April 18, the 2023 Economic Work Conference of Shanghai Industrial Comprehensive Development Zone was held. Li Lei, deputy head of Fengxian District, was invited to attend the meeting and delivered a speech, and members of the leading group of the development zone, middle-level cadres and enterprise representatives attended the meeting. At the meeting, the advanced enterprises in 2022 were commended, and Mengyang Pharmaceutical (Shanghai) Co., Ltd. won the 2022 "Science and Technology Star Award" of Shanghai Industrial Comprehensive Development Zone.

Li Lei expressed her gratitude to the enterprises in the development zone for their contributions to Fengxian, and encouraged them to strengthen their confidence in development, enhance the confidence of entrepreneurship, and grasp the "time" and "potential" of development. She said that the future competition is more of a competition between industrial ecology, the government, parks and enterprises should make multi-directional efforts, Fengxian will give priority to providing land for industrial chain enterprises, give priority to matching relevant support policies, optimize the industrial chain, build industrial clusters, and achieve double effect improvement in quantity and quality. She emphasized that as a comprehensive service platform, the development zone should continue to do a good job in enterprise services, be close to enterprises, accurately focus on the actual difficulties of enterprises, build a platform for enterprise development, expand the market, reduce costs, and expand space; It is necessary to do a good job in various social service guarantee work, accelerate the construction and improvement of people's livelihood service facilities such as talent apartments; It is necessary to accelerate the process reengineering, with a more convenient and comfortable production and living service environment, so that enterprises and entrepreneurs can focus on their main business and seek development without distraction.

Li Yongjie, Secretary of the Party Committee and Chairman of the Development Zone, pointed out that in the past year, under the care of the District Party Committee and the District Government, the Development Zone has faced and overcome difficulties together with the enterprises in the park, and firmly established the platform of the 10 billion park. He said that the development zone will continue to deepen the four-in-one role positioning of "nanny, housekeeper, consultant and government", and take the concept of "specialization, standardization, personalization, effectiveness, continuity and pertinence" as a strong support for deepening, optimizing and strengthening enterprise services. He stressed that the pain points and difficulties of the enterprise are the key focus of the work of the development zone, and the development zone will accurately focus on the actual difficulties of the enterprise, make every effort to coordinate and ensure the supply of factors, reduce costs and expand space for the development of the enterprise to the greatest extent, continuously improve the sense of identity of the enterprise, enhance the adhesion between the enterprise and the park, and sincerely do a good job of the enterprise's "own people", "paving people" and "caring people".

Chen Xian, Deputy Secretary of the Party Committee of the Development Zone, read out the "Decision on Commending the Advanced Enterprises in the Park in 2022", commending the outstanding enterprises that have made outstanding contributions in scientific and technological innovation, quality and quality, the construction of the Comprehensive Bonded Zone, the guidance of the new economy, social welfare, and tax contributions in 2022. Mengyang Pharmaceutical (Shanghai) Co., Ltd. won the 2022 "Science and Technology Star Award" of Shanghai Industrial Comprehensive Development Zone.

As one of the representative enterprises of Shanghai Industrial Comprehensive Development Zone, Mengyang Pharmaceutical will continue to uphold the mission of "improving the quality of life of cancer patients", practice the values of "patient-centered, guided by unmet clinical needs, keep integrity and innovation, and continue to struggle", take the road of high-quality development, and work hard in the field of cancer treatment-related diseases, and write a magnificent chapter!